Table 5.
Outcome results of studies comparing two dosage forms of mebeverine included in meta-analysis
| Study |
Adverse effect |
Outcomes of therapeutic efficacy |
Relief of abdominal pain |
Global or clinical improvement |
||||
| Meb 200 mg | Meb 135 mg | Meb 200 mg | Meb 135 mg | Meb 200 mg | Meb 135 mg | Meb 200 mg | Meb 135 mg | |
| Gilbody et al[24] 2000 | 66/107 | 63/106 | 74/92 | 69/92 | 65/92 | 64/92 | 64/92 | 59/92 |
| Inauen et al[25] 1994 | No serious adverse effect | No serious adverse effects | 19/24 | 23/24 | 22/24 | 19/24 | ||